Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1

Biochemical and Biophysical Research Communications

Volumn 430, Issue 1, 2013, Pages 208-212

  Achour, Mayada ^a   Mousli, Marc ^a   Alhosin, Mahmoud ^a   Ibrahim, Abdulkhaleg ^a   Peluso, Jean ^a   Muller, Christian D ^a   Schini Kerth, Valérie B ^a   Hamiche, Ali ^a   Dhe Paganon, Sirano ^b   Bronner, Christian ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

DNA methyltransferase 1; Epigallocatechin 3 gallate; Tumor suppressor gene; Ubiquitin like containing PHD and Ring finger 1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA METHYLTRANSFERASE 1; EPIGALLOCATECHIN GALLATE; PROTEIN P73; REACTIVE OXYGEN METABOLITE; UBIQUITIN; UBIQUITIN LIKE CONTAINING PHD AND RING FINGER 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; DOWN REGULATION; DRUG PROTEIN BINDING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 85027948894     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.087     Document Type: Article

References (38)

1. Hopfner R., Mousli M., Jeltsch J.M., Voulgaris A., Lutz Y., Marin C., Bellocq J.P., Oudet P., Bronner C. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res. 2000, 60:121-128.
2. Unoki M., Nishidate T., Nakamura Y. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 2004, 23:7601-7610.
3. Trotzier M.A., Bronner C., Bathami K., Mathieu E., Abbady A.Q., Jeanblanc M., Muller C.D., Rochette-Egly C., Mousli M. Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression. Biochem. Biophys. Res. Commun. 2004, 319:590-595.
4. Hopfner R., Mousli M., Oudet P., Bronner C. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression. Anticancer Res. 2002, 22:3165-7310.
5. Hopfner R., Mousli M., Garnier J.M., Redon R., du Manoir S., Chatton B., Ghyselinck N., Oudet P., Bronner C. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression. Gene 2001, 266:15-23.
6. Achour M., Fuhrmann G., Alhosin M., Rondé P., Chataigneau T., Mousli M., Schini-Kerth V.B., Bronner C. UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity. Biochem. Biophys. Res. Commun. 2009, 390:523-528.
7. Bronner C., Fuhrmann G., Chédin F.L., Macaluso M., Dhe-Paganon S. UHRF1 Links the Histone code and DNA Methylation to ensure Faithful Epigenetic Memory Inheritance. Genet. Epigenet. 2009, 2:29-36.
8. Avvakumov G.V., Walker J.R., Xue S., Li Y., Duan S., Bronner C., Arrowsmith C.H., Dhe-Paganon S. Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature 2008, 455:822-825.
9. Arita K., Ariyoshi M., Tochio H., Nakamura N., Shirakawa M. Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 2008, 455:818-821.
10. Hashimoto H., Horton J.R., Zhang X., Bostick M., Jacobsen S.E., Cheng X. The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 2008, 455:826-829.
11. Achour M., Jacq X., Rondé P., Alhosin M., Charlot C., Chataigneau T., Jeanblanc M., Macaluso M., Giordano A., Hughes A.D., Schini-Kerth V.B., Bronner C. The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. Oncogene 2008, 27:2187-2197.
12. Syeda F., Fagan R.L., Wean M., Avvakumov G.V., Walker J.R., Xue S., Dhe-Paganon S., Brenner C. The replication focus targeting sequence (RFTS) domain is an DNA-competitive inhibitor of Dnmt1. J. Biol. Chem. 2011, 286:15344-15351.
13. Frauer C., Hoffmann T., Bultmann S., Casa V., Cardoso M.C., Antes I., Leonhardt H. Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain. PLoS One 2011, 6(6):e21306.
14. Singh B.N., Shankar S., Srivastava R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 2011, 82:1807-1821.
15. Fang M.Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., Welsh W., Yang C.S. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63:7563-7570.
16. Pandey M., Shukla S., Gupta S. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int. J. Cancer 2010, 126:2520-2533.
17. Fini L., Selgrad M., Fogliano V., Graziani G., Romano M., Hotchkiss E., Daoud Y.A., De Vol E.B., Boland C.R., Ricciardiello L. Annurca apple polyphenols have potent demethylating activity and can reactivate silenced tumor suppressor genes in colorectal cancer cells. J. Nutr. 2007, 137:2622-2628.
18. Nandakumar V., Vaid M., Katiyar S.K. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 2011, 32:537-544.
19. Miyamoto Y., Sano M., Haylor J.L., El Nahas A.M. (-)-Epigallocatechin 3-O-gallate (EGCG)-induced apoptosis in normal rat kidney interstitial fibroblast (NRK-49F) cells. J. Toxicol. Sci. 2008, 33:367-370.
20. Paul B., Hayes C.S., Kim A., Athar M., Gilmour S.K. Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice. Carcinogenesis 2005, 26:119-124.
21. Qanungo S., Das M., Haldar S., Basu A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 2005, 26:958-967.
22. Harakeh S., Abu-El-Ardat K., Diab-Assaf M., Niedzwiecki A., El-Sabban M., Rath M. Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells. Med. Oncol. 2008, 25:30-39.
23. Siddiqui I.A., Malik A., Adhami V.M., Asim M., Hafeez B.B., Sarfaraz S., Mukhtar H. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 2008, 27:2055-2063.
24. Siegelin M.D., Habel A., Gaiser T. Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma. Neurosci. Lett. 2008, 448:161-165.
25. Abbady A.Q., Bronner C., Bathami K., Muller C.D., Jeanblanc M., Mathieu E., Klein J.P., Candolfi E., Mousli M. ICBP90 expression is downregulated in apoptosis-induced Jurkat cells. Ann. NY Acad. Sci. 2003, 1010:300-303.
26. Jin W., Chen L., Chen Y., Xu S.G., Di G.H., Yin W.J., Wu J., Shao Z.M. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res. Treat. 2010, 123:359-373.
27. Bronner C., Achour M., Arima Y., Chataigneau T., Saya H., Schini-Kerth V.B. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?. Pharmacol. Ther. 2007, 115:419-434.
28. Alhosin M., Sharif T., Mousli M., Etienne-Selloum N., Fuhrmann G., Schini-Kerth V.B., Bronner C. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J. Exp. Clin. Cancer Res. 2011, 30:41.
29. Alhosin M., Abusnina A., Achour M., Sharif T., Muller C., Peluso J., Chataigneau T., Lugnier C., Schini-Kerth V.B., Bronner C., Fuhrmann G. Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1. Biochem. Pharmacol. 2010, 79:1251-1260.
30. Nichols J.A., Katiyar S.K. Skin photoprotection by natural polyphenols: anti-inflammatory, anti-oxidant and DNA repair mechanisms. Arch. Dermatol. Res. 2010, 302:71-83.
31. Katiyar S.K., Elmets C.A. Green tea polyphenolic antioxidants and skin photoprotection. Int. J. Oncol. 2001, 18:1307-1313.
32. Lee W.J., Shim J.Y., Zhu B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 2005, 68:1018-1030.
33. McDermott C., O'Donoghue M.H., Heffron J.J. N-Hexane toxicity in Jurkat T-cells is mediated by reactive oxygen species. Arch. Toxicol. 2008, 82:165-171.
34. Tian B., Sun Z., Xu Z., Hu Y. Chemiluminescence analysis of the prooxidant andantioxidant effects of epigallocatechin-3-gallate. Asia Pac. J. Clin. Nutr. 2007, 16(Suppl. 1). 153-157.
35. Boschmann M., Thielecke F. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J. Am. Coll. Nutr. 2007, 26:389S-395S.
36. Min N.Y., Kim J.H., Choi J.H., Liang W., Ko Y.J., Rhee S., Bang H., Ham S.W., Park A.J., Lee K.H. Selective death of cancer cells by preferential induction of reactive oxygen species in response to (-)-epigallocatechin-3-gallate. Biochem. Biophys. Res. Commun. 2012, 421:91-97.
37. Kim C.H., Moon S.K. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells. Arch. Biochem. Biophys. 2005, 435:264-272.
38. Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., He C., Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.